AGP Picks
View all

Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on June 4, 2026

EQIQs Launches Relationship and Team Intelligence Platform
FEDCON See Promise in New Federal Acquisition Rules
Martti Parent Company Equiti Recognized as a Leader in the 2026 Slator Language Service Provider Index
Altera Announces New AI, WooCommerce Migration, and Metafield Tools for Shopify Merchants
TENEX.ai Appoints Richard Rogers as Chief Marketing Officer to Accelerate Global Growth
Science is HERE All Summer at The Tech Interactive
Unstoppable Branding Agency Announces Upcoming Global Media Features for Dr. Mark Leong, Tina Sue, Karen Romine, and María Esther Panesso Mercado
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
Satellogic to Participate in June Investor Conferences
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 
ServiceTitan Announces Fiscal First Quarter Financial Results
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Climb Global Solutions to Host Investor Day on July 7, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.